KR100870243B1 - 세포의 실시간 모니터링용 이광자 염료, 그 제조방법 및이를 이용한 세포의 실시간 모니터링 방법 - Google Patents
세포의 실시간 모니터링용 이광자 염료, 그 제조방법 및이를 이용한 세포의 실시간 모니터링 방법 Download PDFInfo
- Publication number
- KR100870243B1 KR100870243B1 KR1020070051133A KR20070051133A KR100870243B1 KR 100870243 B1 KR100870243 B1 KR 100870243B1 KR 1020070051133 A KR1020070051133 A KR 1020070051133A KR 20070051133 A KR20070051133 A KR 20070051133A KR 100870243 B1 KR100870243 B1 KR 100870243B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- compound
- photon
- cells
- time monitoring
- Prior art date
Links
- 238000012544 monitoring process Methods 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 26
- 239000000523 sample Substances 0.000 title description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 142
- 238000000695 excitation spectrum Methods 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims description 89
- 210000004027 cell Anatomy 0.000 claims description 54
- 239000000975 dye Substances 0.000 claims description 41
- -1 t-butyldimethylsilanyloxy group Chemical group 0.000 claims description 16
- 238000002073 fluorescence micrograph Methods 0.000 claims description 8
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 5
- 210000000805 cytoplasm Anatomy 0.000 claims description 4
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical compound C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 19
- 230000035699 permeability Effects 0.000 abstract description 10
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 12
- 230000005284 excitation Effects 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000002189 fluorescence spectrum Methods 0.000 description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 8
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 8
- 238000005160 1H NMR spectroscopy Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- KOSSUHOZCLHUPB-UHFFFAOYSA-N 1-hydroxy-6-methoxynaphthalene-2-carbaldehyde Chemical compound OC1=C(C=O)C=CC2=CC(OC)=CC=C21 KOSSUHOZCLHUPB-UHFFFAOYSA-N 0.000 description 6
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 101000834948 Homo sapiens Tomoregulin-2 Proteins 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 102100026160 Tomoregulin-2 Human genes 0.000 description 6
- 238000000862 absorption spectrum Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229940125904 compound 1 Drugs 0.000 description 5
- 229940125782 compound 2 Drugs 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 239000012679 serum free medium Substances 0.000 description 5
- SNKAWJBJQDLSFF-NVKMUCNASA-N 1,2-dioleoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC SNKAWJBJQDLSFF-NVKMUCNASA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- IOOGLAIWRBBWCE-UHFFFAOYSA-N 6-(dimethylamino)-1-hydroxynaphthalene-2-carbaldehyde Chemical compound OC1=C(C=O)C=CC2=CC(N(C)C)=CC=C21 IOOGLAIWRBBWCE-UHFFFAOYSA-N 0.000 description 4
- 229910052786 argon Inorganic materials 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000002691 unilamellar liposome Substances 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000012091 fetal bovine serum Substances 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical class O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- RAIYODFGMLZUDF-UHFFFAOYSA-N piperidin-1-ium;acetate Chemical compound CC([O-])=O.C1CC[NH2+]CC1 RAIYODFGMLZUDF-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
- VAHSNBMGRCBGJJ-UHFFFAOYSA-N CN(C)C1=CC=C2C(CCC(C=O)=C2O)=C1 Chemical compound CN(C)C1=CC=C2C(CCC(C=O)=C2O)=C1 VAHSNBMGRCBGJJ-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- RBPWQIKZHBYIEY-PXCYNBOKSA-N [(2r)-2,3-bis[(z)-octadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC RBPWQIKZHBYIEY-PXCYNBOKSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 2
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 230000005281 excited state Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- LLAJSQUPLZEFNZ-UHFFFAOYSA-N methyl 8-(dimethylamino)-2-oxobenzo[h]chromene-3-carboxylate Chemical compound C1=C(N(C)C)C=CC2=C(OC(C(C(=O)OC)=C3)=O)C3=CC=C21 LLAJSQUPLZEFNZ-UHFFFAOYSA-N 0.000 description 2
- ANGDWNBGPBMQHW-UHFFFAOYSA-N methyl cyanoacetate Chemical compound COC(=O)CC#N ANGDWNBGPBMQHW-UHFFFAOYSA-N 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 101150037438 tpm gene Proteins 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- FNSQPQKPPGALFA-UHFFFAOYSA-N 6-hydroxy-3,4-dihydro-2h-naphthalen-1-one Chemical compound O=C1CCCC2=CC(O)=CC=C21 FNSQPQKPPGALFA-UHFFFAOYSA-N 0.000 description 1
- NRZJOTSUPLCYDJ-UHFFFAOYSA-N 7-(ethylamino)-6-methyl-4-(trifluoromethyl)chromen-2-one Chemical compound O1C(=O)C=C(C(F)(F)F)C2=C1C=C(NCC)C(C)=C2 NRZJOTSUPLCYDJ-UHFFFAOYSA-N 0.000 description 1
- GNTVRRVTMFICNB-UHFFFAOYSA-N C1=C(C(O)=O)C(=O)OC2=C1C=CC1=CC(OC)=CC=C21 Chemical compound C1=C(C(O)=O)C(=O)OC2=C1C=CC1=CC(OC)=CC=C21 GNTVRRVTMFICNB-UHFFFAOYSA-N 0.000 description 1
- 241000122205 Chamaeleonidae Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical class COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 210000002403 aortic endothelial cell Anatomy 0.000 description 1
- SHDCBZUQYOSCFY-UHFFFAOYSA-N benzo[h]chromen-2-one Chemical class C1=CC=CC2=C(OC(=O)C=C3)C3=CC=C21 SHDCBZUQYOSCFY-UHFFFAOYSA-N 0.000 description 1
- 238000012984 biological imaging Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229940043267 rhodamine b Drugs 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 150000003436 stilbenoids Chemical class 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/84—Systems specially adapted for particular applications
- G01N21/88—Investigating the presence of flaws or contamination
- G01N21/91—Investigating the presence of flaws or contamination using penetration of dyes, e.g. fluorescent ink
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
화합물1 ) | [10-4 ε] | △υ2) | Φ3) | 4) | δmax e | |
제조예 1 | 391(1.99) | 481 | 4785 | 0.82 | 780 | 140 |
제조예 36) | 397(1.37) | 482,551 | 4442, 7040 | 0.48 | 780 | 270 |
제조예 4 | 453(1.54) | 570 | 4531 | 0.19 | 880 | 350 |
제조예 5 | 457(2.28) | 590 | 4933 | 0.050 | 940 | 470 |
Claims (9)
- 제1항에 있어서, 상기 화학식 1의 화합물은 이광자 여기 스펙트럼 (nm)의 최대 파장 범위가 780nm 내지 940nm인 것을 특징으로 하는 세포의 실시간 모니터링용 이광자 염료.
- 제1항 또는 제2항에 따른 이광자 염료를 관찰 대상이 되는 세포질 내로 주입한 후 방출되는 이광자 여기 형광 영상을 관찰하는 단계를 포함하는 세포의 실시간 모니터링 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070051133A KR100870243B1 (ko) | 2007-05-25 | 2007-05-25 | 세포의 실시간 모니터링용 이광자 염료, 그 제조방법 및이를 이용한 세포의 실시간 모니터링 방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070051133A KR100870243B1 (ko) | 2007-05-25 | 2007-05-25 | 세포의 실시간 모니터링용 이광자 염료, 그 제조방법 및이를 이용한 세포의 실시간 모니터링 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100870243B1 true KR100870243B1 (ko) | 2008-11-25 |
Family
ID=40284699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070051133A KR100870243B1 (ko) | 2007-05-25 | 2007-05-25 | 세포의 실시간 모니터링용 이광자 염료, 그 제조방법 및이를 이용한 세포의 실시간 모니터링 방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100870243B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101779923B1 (ko) * | 2015-10-06 | 2017-09-19 | 아주대학교산학협력단 | 미토콘드리아 내 pH 검출용 가변색 이광자 형광 프로브 및 이의 제조방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040157231A1 (en) | 2001-07-02 | 2004-08-12 | Niko Meltola | Two-photon absorbing dipyrromethenboron difluoride dyes and their applications |
JP2005000629A (ja) * | 2003-06-14 | 2005-01-06 | Takehiko Oki | デスクマット及びデスクシート |
JP2005001231A (ja) * | 2003-06-11 | 2005-01-06 | Toyo Tire & Rubber Co Ltd | ゴム連続混練押出機 |
JP2005213434A (ja) | 2004-01-30 | 2005-08-11 | Kyoto Univ | ジアリールアミノ基を有するピラン誘導体からなる二光子吸収材料 |
-
2007
- 2007-05-25 KR KR1020070051133A patent/KR100870243B1/ko active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040157231A1 (en) | 2001-07-02 | 2004-08-12 | Niko Meltola | Two-photon absorbing dipyrromethenboron difluoride dyes and their applications |
JP2005001231A (ja) * | 2003-06-11 | 2005-01-06 | Toyo Tire & Rubber Co Ltd | ゴム連続混練押出機 |
JP2005000629A (ja) * | 2003-06-14 | 2005-01-06 | Takehiko Oki | デスクマット及びデスクシート |
JP2005213434A (ja) | 2004-01-30 | 2005-08-11 | Kyoto Univ | ジアリールアミノ基を有するピラン誘導体からなる二光子吸収材料 |
Non-Patent Citations (2)
Title |
---|
논문2005.06.29 |
논문2005.12.31 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101779923B1 (ko) * | 2015-10-06 | 2017-09-19 | 아주대학교산학협력단 | 미토콘드리아 내 pH 검출용 가변색 이광자 형광 프로브 및 이의 제조방법 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10161932B2 (en) | Azetidine-substituted fluorescent compounds | |
Kucherak et al. | Dipolar 3-methoxychromones as bright and highly solvatochromic fluorescent dyes | |
US4774339A (en) | Chemically reactive dipyrrometheneboron difluoride dyes | |
US8772048B2 (en) | Fluorogenic compounds converted to fluorophores by photochemical or chemical means and their use in biological systems | |
JP6275256B2 (ja) | ボロンジピロメテン蛍光プローブ、その製造方法及び応用 | |
JP5526124B2 (ja) | 近赤外蛍光化合物 | |
CN102146284B (zh) | 一种比率型荧光探针及其应用 | |
CN114031614B (zh) | 一种双细胞器成像、细胞活力评估和光动力癌细胞消融的荧光探针及制备和应用 | |
US9182350B2 (en) | Naphthalene-based two-photon fluorescent probes, preparation method and use thereof | |
CN112521413A (zh) | 一种双通道检测粘度和过氧化氢的荧光探针及制备和应用 | |
KR101233679B1 (ko) | 서로 다른 형광색의 이광자 형광 프로브를 이용하여 나트륨/칼슘 활성을 동시에 이미지화하는 방법 및 이광자 형광 프로브의 제조방법 | |
KR100870243B1 (ko) | 세포의 실시간 모니터링용 이광자 염료, 그 제조방법 및이를 이용한 세포의 실시간 모니터링 방법 | |
KR101590527B1 (ko) | 새로운 인도시아닌 유도체 화합물, 상기 화합물을 포함하는 조성물, 및 싸이올기 함유 화합물 검출용 센서 | |
Yang et al. | Dual-lifetime luminescent probe for time-resolved ratiometric oxygen sensing and imaging | |
WO2020120636A1 (en) | Fluorescence dye | |
KR100886722B1 (ko) | 세포질 내 마그네슘의 실시간 모니터링용 이광자 염료, 그제조방법 및 이를 이용한 세포질 내 마그네슘의 실시간모니터링 방법 | |
Zhang et al. | Rigidify styryl-pyridinium dyes to benzo [h] coumarin-based bright two-photon fluorescent probes for cellular bioimaging | |
CN111978247B (zh) | 一种双光子荧光探针及其制备方法和应用 | |
KR20230128703A (ko) | 세포질 칼슘과 리소좀 내 산성도를 동시에 검출할 수 있는 이광자 형광 프로브 | |
KR20230128705A (ko) | 세포막에서 칼슘을 표지할 수 있는 이광자 청색 표지자 | |
KR20230128704A (ko) | 미토콘드리아 칼슘을 표지할 수 있는 이광자 청색 형광 프로브 | |
Wang | Development of Chemical Probes for Studying K+ in biology | |
KR20130039532A (ko) | 생체 내 영상화를 위한 이광자 리소좀 표지자, 그 제조방법 및 이를 이용한 생체 내 리소좀 영상화 방법 | |
Srikun | New Chemical Tools for Fluorescent Detection of Hydrogen Peroxide in Living Cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121004 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20131024 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20141014 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20151117 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20161107 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20171013 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20181025 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20191118 Year of fee payment: 12 |